Cargando…
ApoE Lipidation as a Therapeutic Target in Alzheimer’s Disease
Apolipoprotein E (APOE) is the major cholesterol carrier in the brain, affecting various normal cellular processes including neuronal growth, repair and remodeling of membranes, synaptogenesis, clearance and degradation of amyloid β (Aβ) and neuroinflammation. In humans, the APOE gene has three comm...
Autores principales: | Lanfranco, Maria Fe, Ng, Christi Anne, Rebeck, G. William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503657/ https://www.ncbi.nlm.nih.gov/pubmed/32882843 http://dx.doi.org/10.3390/ijms21176336 |
Ejemplares similares
-
The Synergistic Effects of APOE Genotype and Obesity on Alzheimer’s Disease Risk
por: Jones, Nahdia S., et al.
Publicado: (2018) -
Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk
por: Tai, Leon M, et al.
Publicado: (2014) -
ApoE4: an emerging therapeutic target for Alzheimer’s disease
por: Safieh, Mirna, et al.
Publicado: (2019) -
CCR5 deficiency normalizes TIMP levels, working memory, and gamma oscillation power in APOE4 targeted replacement mice
por: Greco, Griffin A., et al.
Publicado: (2023) -
Cancer Chemotherapy Related Cognitive Impairment and the Impact of the Alzheimer’s Disease Risk Factor APOE
por: Fernandez, Harvey R., et al.
Publicado: (2020)